Peter McCullough

… The COVID-19 vaccine manufacturers with the US FDA excluded pregnant women and women of childbearing potential from being studied in randomized trials because of maternal-fetal risks with lipid nanoparticles, mRNA, and PEG. It is strict regulatory practice, that when a group is excluded from the registrational randomized trials of a new product, that group is also prohibited from taking or using that medicine in practice for obvious safety reasons. That consideration is always applied to pregnancy without exception.

Early in the campaign, the COVID-19 vaccines were declared “Pregnancy Category X” in a publication led by Dr. McCullough and fetal loss expert Dr. Raphael Stricker. Despite this warning, the CDC/FDA COVID-19 vaccination program violated that regulatory standard and, at first gently and later with much force, strongly encouraged pregnant women to take risks and accept one of the COVID-19 vaccines.